These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36446361)
1. The roles of CPSF6 in proliferation, apoptosis and tumorigenicity of lung adenocarcinoma. Zu Y; Wang D; Ping W; Sun W Aging (Albany NY); 2022 Nov; 14(22):9300-9316. PubMed ID: 36446361 [TBL] [Abstract][Full Text] [Related]
2. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling. Liu Z; Hu Z; Cai X; Liu S Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710 [TBL] [Abstract][Full Text] [Related]
3. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis. Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341 [TBL] [Abstract][Full Text] [Related]
5. SLITRK6 promotes the progression of lung adenocarcinoma by regulating PI3K/AKT/mTOR signaling and Warburg effect. Yu F; Zhao X; Li M; Meng M Apoptosis; 2023 Aug; 28(7-8):1216-1225. PubMed ID: 37219677 [TBL] [Abstract][Full Text] [Related]
6. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway. Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma. Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091 [TBL] [Abstract][Full Text] [Related]
8. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway. Chen X; Zhang W; Xu X World J Surg Oncol; 2021 Aug; 19(1):232. PubMed ID: 34362378 [TBL] [Abstract][Full Text] [Related]
9. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway. Zhu HE; Yin JY; Chen DX; He S; Chen H Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation. Chen W; Guo W; Li M; Shi D; Tian Y; Li Z; Wang J; Fu L; Xiao X; Liu QQ; Wang S; Huang W; Deng W PLoS One; 2013; 8(12):e82728. PubMed ID: 24358221 [TBL] [Abstract][Full Text] [Related]
11. DNA repair/recombination protein 54L promotes the progression of lung adenocarcinoma by activating mTORC1 pathway. Liu C; Ren W; Zhang Z; Guan J Hum Cell; 2023 Jan; 36(1):421-433. PubMed ID: 36454390 [TBL] [Abstract][Full Text] [Related]
12. RACGAP1 promotes lung cancer cell proliferation through the PI3K/AKT signaling pathway. Xu Z; Wu S; Tu J; Wang M; Liang W; Cheng J; Guan J; Xu J Sci Rep; 2024 Apr; 14(1):8694. PubMed ID: 38622149 [TBL] [Abstract][Full Text] [Related]
13. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818 [No Abstract] [Full Text] [Related]
15. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503 [TBL] [Abstract][Full Text] [Related]
16. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543. Xu Y; Lin L; Lv D; Yan S; He S; Ge H Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399 [TBL] [Abstract][Full Text] [Related]
17. COL3A1-positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL-PI3K-AKT axis. Zhang M; Liang Y; Song P J Gene Med; 2024 Jan; 26(1):e3573. PubMed ID: 37547956 [TBL] [Abstract][Full Text] [Related]
18. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells. Ma S; Wang X; Zhang Z; Liu D Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007 [TBL] [Abstract][Full Text] [Related]
19. PDGFBB facilitates tumorigenesis and malignancy of lung adenocarcinoma associated with PI3K-AKT/MAPK signaling. Xiu-Ying H; Yue-Xiang Z; Hui-Si Y; Hong-Zhou Y; Qing-Jie X; Ting-Hua W Sci Rep; 2024 Feb; 14(1):4191. PubMed ID: 38378786 [TBL] [Abstract][Full Text] [Related]
20. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression. Tan S; Zhang M; Shi X; Ding K; Zhao Q; Guo Q; Wang H; Wu Z; Kang Y; Zhu T; Sun J; Zhao X J Exp Clin Cancer Res; 2021 Mar; 40(1):85. PubMed ID: 33648552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]